ATE490346T1 - In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes - Google Patents

In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes

Info

Publication number
ATE490346T1
ATE490346T1 AT01975218T AT01975218T ATE490346T1 AT E490346 T1 ATE490346 T1 AT E490346T1 AT 01975218 T AT01975218 T AT 01975218T AT 01975218 T AT01975218 T AT 01975218T AT E490346 T1 ATE490346 T1 AT E490346T1
Authority
AT
Austria
Prior art keywords
vaccine
immunogenicity
test methods
vitro test
immunogenically
Prior art date
Application number
AT01975218T
Other languages
English (en)
Inventor
Mark Schenerman
Sheau-Chiann Wang
Robert Strouse
Joann Suzich
Wendy White
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Application granted granted Critical
Publication of ATE490346T1 publication Critical patent/ATE490346T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT01975218T 2000-09-18 2001-09-17 In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes ATE490346T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23343900P 2000-09-18 2000-09-18
PCT/US2001/028877 WO2002024961A1 (en) 2000-09-18 2001-09-17 In vitro assay for measuring the immunogenicity of a vaccine

Publications (1)

Publication Number Publication Date
ATE490346T1 true ATE490346T1 (de) 2010-12-15

Family

ID=22877259

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01975218T ATE490346T1 (de) 2000-09-18 2001-09-17 In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes

Country Status (9)

Country Link
US (1) US20020160358A1 (de)
EP (1) EP1319089B1 (de)
JP (1) JP4746819B2 (de)
AT (1) ATE490346T1 (de)
AU (1) AU2001294565A1 (de)
CA (1) CA2422635C (de)
DE (1) DE60143583D1 (de)
ES (1) ES2357381T3 (de)
WO (1) WO2002024961A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833724B2 (en) * 2006-03-20 2010-11-16 Teva Women's Health, Inc. Methods for comparing the immunogenicity of products and uses thereof
GB0607462D0 (en) * 2006-04-13 2006-05-24 Avecia Ltd Assay
WO2008150276A2 (en) * 2006-09-26 2008-12-11 The Board Of Regents Of The University Of Texas System Virus coated nanoparticles and uses thereof
US10732180B2 (en) 2014-06-04 2020-08-04 Indevr, Inc. Universal capture array for multiplexed subtype-specific quantification and stability determination of influenza proteins
EP3634996A4 (de) * 2017-06-06 2021-03-03 InDevR, Inc. Gleichzeitige in-vitro-analyse der impfstoffpotenz und toxinkonzentration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0422981A1 (de) * 1989-10-10 1991-04-17 Institut National De La Recherche Agronomique (Inra) Reagenzien und Verfahren zur immunochemischen Bestimmung des Denaturierungsgrads von proteinartigen Substanzen
ES2263406T3 (es) * 1993-03-09 2011-06-06 The University Of Rochester Producción de la proteína de capside l1 del papilomavirus humano hpv-11 y partículas de tipo virus.
US5654419A (en) * 1994-02-01 1997-08-05 The Regents Of The University Of California Fluorescent labels and their use in separations
ATE333501T1 (de) * 1997-09-05 2006-08-15 Medimmune Inc Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virus- ähnlichen tielchen (vlps)

Also Published As

Publication number Publication date
WO2002024961A1 (en) 2002-03-28
ES2357381T3 (es) 2011-04-25
JP2004510144A (ja) 2004-04-02
EP1319089A1 (de) 2003-06-18
DE60143583D1 (de) 2011-01-13
CA2422635A1 (en) 2002-03-28
EP1319089B1 (de) 2010-12-01
JP4746819B2 (ja) 2011-08-10
CA2422635C (en) 2011-11-15
EP1319089A4 (de) 2004-07-14
AU2001294565A1 (en) 2002-04-02
US20020160358A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
CR20150350A (es) Proceso para preparar conjugados de anticuerpo y maytansinoide
JP2004503248A5 (de)
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
DE60228557D1 (de) Candida-nachweis
DE60326336D1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
DE60137331D1 (de) Verfahren zur abschätzung des ortes eines gerätes
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
WO2006093797A3 (en) Method and kit for detecting porcine reproductive and respiratory syndrome virus
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE458824T1 (de) Zellfreie in-vitro-transkription und translation von membranproteinen in gebundene planare lipidschichten
ATE440283T1 (de) Sensor zur lumineszenz-optischen bestimmung eines analyten
ES2194116T3 (es) Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.
ATE299589T1 (de) Verfahren zur bestimmung von substanzen mittels der evaneszenzfeldmethode
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
ATE490346T1 (de) In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes
ATE478337T1 (de) Methoden zum nachweis analyten in proben
ATE335203T1 (de) Test für anti-transglutaminase-antikörper
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE313799T1 (de) Nachweis von hla-g
HUP0100948A2 (hu) Antitest kompeticiós teszt (AKT) P-glikoprotein és egyéb sejtfelszíni receptorok, pumpák és fehérjék konformáció-változásainak kvalitatív, illetve konformáció-függő kvantitatív kimutatására és annak alkalmazásai
DE50113202D1 (de) Verfahren zur analyse von stuhlproben für diagnostische zwecke

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties